RecruitingNot applicableNCT06357260

Pregabalin as an add-on Therapy to Carbamazepine in Trigeminal Neuralgia Patients

Studying Trigeminal neuralgia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Postgraduate Institute of Dental Sciences Rohtak
Principal Investigator
Shifa Akhtar, BDS
Post Graduate Institute of Dental Sciences ,Rohtak
Intervention
Pregabalin and Carbamazepine(drug)
Enrollment
50 enrolled
Eligibility
25-80 years · All sexes
Timeline
2024 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06357260 on ClinicalTrials.gov

Other trials for Trigeminal neuralgia

Additional recruiting or active studies for the same condition.

See all trials for Trigeminal neuralgia →

← Back to all trials